ERLIN1: A central regulator of protein quality control, lipid homeostasis, and cellular signaling at the endoplasmic reticulum
Cellular Signalling · 2026-02 · 138 · 112224
DOI: 10.1016/j.cellsig.2025.112224 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-02. Verfasst von Hyojeong Cho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea. Hauptthemen laut MEDLINE: Endoplasmic Reticulum, Membrane Proteins, Signal Transduction, Lipid Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Chungnam National University, National Research Foundation of Korea, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Endoplasmic reticulum lipid raft-associated protein 1 (ERLIN1) is an endoplasmic reticulum (ER)-resident stomatin/prohibitin/flotillin/HflK/C (SPFH) family protein that assembles into oligomeric complexes within detergent-resistant membrane domains. ERLIN1 regulates multiple cellular functions, including protein quality control, calcium signaling, and lipid metabolism. Together with ERLIN2, it forms ER-associated degradation (ERAD) nanodomains through interactions with RING finger protein 170 (RNF170) and transmembrane and ubiquitin-like domain-containing 1 (TMUB1). These specialized domains facilitate the degradation of inositol 1,4,5-trisphosphate receptor type 1 (IP3R) via the ERAD pathway. ERLIN1 also controls cholesterol metabolism by inhibiting sterol regulatory element-binding protein (SREBP) activation and promoting 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) degradation. In addition, it blocks cholesterol esterification, thereby enhancing cholesterol transport to the Golgi apparatus. ERLIN1 further regulates cell fate by promoting autophagy and suppressing apoptosis; in complex with ERLIN2, it interacts with activating molecule in Beclin 1-regulated autophagy protein 1 (AMBRA1) at mitochondria-associated membranes to initiate autophagy and binds phosphatidylinositol 3-phosphate to stabilize autophagy signaling. Its overexpression enhances tumor progression, whereas silencing triggers apoptosis in colorectal cancer. Mutations in ERLIN1 are linked to neurodegenerative diseases such as hereditary spastic paraplegia type 62 and atypical amyotrophic lateral sclerosis. The ERLIN1/2 complex also influences immune responses and viral replication through cholesterol regulation. Collectively, these diverse and integrated functions highlight the potential of ERLIN1 as a therapeutic target in cancer, metabolic, neurodegenerative, and infectious diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, College of Medicine, Chungnam National University, Daejeon 35015, South Korea.
- Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon 35015, South Korea; Department of Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Institute for Cancer Research,…
Förderung
- Chungnam National University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
Zitieren
APA
Cho, H., Lee, B., Son, C., Choi, J., Eom, S., & Park, J. (2026). ERLIN1: A central regulator of protein quality control, lipid homeostasis, and cellular signaling at the endoplasmic reticulum. Cellular Signalling, 138, 112224. https://doi.org/10.1016/j.cellsig.2025.112224
Vancouver
Cho H, Lee B, Son C, Choi J, Eom S, Park J. ERLIN1: A central regulator of protein quality control, lipid homeostasis, and cellular signaling at the endoplasmic reticulum. Cellular Signalling. 2026;138:112224. doi:10.1016/j.cellsig.2025.112224
BibTeX
@article{Cho2026,
author = {Cho, Hyojeong and Lee, Beomwoo and Son, Changgyu and Choi, Jaeseok and Eom, Sunho and Park, Jongsun},
title = {ERLIN1: A central regulator of protein quality control, lipid homeostasis, and cellular signaling at the endoplasmic reticulum},
journal = {Cellular Signalling},
year = {2026},
volume = {138},
pages = {112224},
doi = {10.1016/j.cellsig.2025.112224}
}
EUVIMED